We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

81 hedge funds and large institutions have $145M invested in Immunomedics Inc in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

4% less call options, than puts

Call options by funds: $11.8M | Put options by funds: $12.3M

2% less funds holding

Funds holding: 8381 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

30% less capital invested

Capital invested by funds: $208M → $145M (-$63.1M)

Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
2.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
31
Reduced
25
Closed
10
Calls
$11.8M
Puts
$12.3M
Net Calls
-$535K
Net Calls Change
-$5.69M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$57.4M +$133K +29,799 +0.2%
BFA
2
BlackRock Fund Advisors
California
$13.6M -$87.1K -19,570 -0.7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$11.8M +$366K +82,284 +3%
BIT
4
BlackRock Institutional Trust
California
$11.3M +$264K +59,342 +2%
SCA
5
SAC Capital Advisors
Connecticut
$6.43M -$1.83M -411,452 -23%
State Street
6
State Street
Massachusetts
$5.83M +$90.3K +20,282 +2%
Northern Trust
7
Northern Trust
Illinois
$5.03M +$86K +19,306 +2%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$2.87M +$1.44M +324,147 +108%
WCM Investment Management
9
WCM Investment Management
California
$2.23M -$144K -32,271 -6%
PAM
10
Panagora Asset Management
Massachusetts
$2.12M +$25.1K +5,629 +1%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$1.81M +$1.21M +271,518 +224%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$1.72M -$66K -14,815 -4%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$1.69M -$167K -37,470 -9%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.66M +$141K +31,705 +10%
TCIM
15
TIAA CREF Investment Management
New York
$1.46M +$90K +20,207 +7%
Citadel Advisors
16
Citadel Advisors
Florida
$1.16M +$246K +55,290 +28%
Zurich Cantonal Bank
17
Zurich Cantonal Bank
Switzerland
$1.15M +$1.11M +250,000 New
BCM
18
Bridgeway Capital Management
Texas
$1.04M -$116K -26,000 -10%
BIM
19
BlackRock Investment Management
Delaware
$950K -$18K -4,050 -2%
BP
20
Banyan Partners
Florida
$897K +$89.1K +20,000 +11%
SCM
21
Sigma Capital Management
Connecticut
$690K -$5.45M -1,225,000 -89%
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$626K -$16.9K -3,794 -2%
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$609K +$2.67K +600 +0.5%
Charles Schwab
24
Charles Schwab
California
$595K
B
25
Bailard
California
$547K -$512K -115,000 -49%

IMMU Hedge Fund Activity: Q4 2013 in Review

81 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2013, worth a combined $145M — down 30% from $208M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IMMU and 8 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 31 added.

The largest buyer was Susquehanna International Group, adding an estimated $1.44M. The largest seller was Sigma Capital Management, cutting an estimated $5.45M.

  • 81 institutional investors held Immunomedics Inc (IMMU) as of Q4 2013, down from 83 in Q3 2013.
  • Funds reported $145M of Immunomedics Inc stock for Q4 2013, down 30% quarter-over-quarter.
  • 8 funds opened new Immunomedics Inc positions in Q4 2013 and 10 closed out, a net change of -2 holders.
  • The largest Immunomedics Inc buyer in Q4 2013 was Susquehanna International Group, an estimated $1.44M added.
  • The largest Immunomedics Inc seller in Q4 2013 was Sigma Capital Management, an estimated $5.45M sold.

Based on aggregated 13F filings for Q4 2013.